369 related articles for article (PubMed ID: 15001968)
21. Crohn's Disease Is Associated with Decreased CYP3A4 and P-Glycoprotein Protein Expression.
Wilson A; Urquhart BL; Ponich T; Chande N; Gregor JC; Beaton M; Kim RB
Mol Pharm; 2019 Sep; 16(9):4059-4064. PubMed ID: 31393129
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
Pinto AG; Wang YH; Chalasani N; Skaar T; Kolwankar D; Gorski JC; Liangpunsakul S; Hamman MA; Arefayene M; Hall SD
Clin Pharmacol Ther; 2005 Mar; 77(3):178-88. PubMed ID: 15735612
[TBL] [Abstract][Full Text] [Related]
23. Characterization of human small intestinal cytochromes P-450.
Zhang QY; Dunbar D; Ostrowska A; Zeisloft S; Yang J; Kaminsky LS
Drug Metab Dispos; 1999 Jul; 27(7):804-9. PubMed ID: 10383924
[TBL] [Abstract][Full Text] [Related]
24. Construction and application of double-transfected cells expressing the human transporter P-glycoprotein and cytochrome P450 3A4.
Hu HH; Su C; Jiang Y; Yu LS; Liu Y; Tian Y; Xu SY; Zhou H; He X; Jiang HD; Zeng S
Pharmazie; 2013 Oct; 68(10):816-20. PubMed ID: 24273886
[TBL] [Abstract][Full Text] [Related]
25. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.
Lown KS; Kolars JC; Thummel KE; Barnett JL; Kunze KL; Wrighton SA; Watkins PB
Drug Metab Dispos; 1994; 22(6):947-55. PubMed ID: 7895614
[TBL] [Abstract][Full Text] [Related]
26. Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers.
Fontana RJ; Lown KS; Paine MF; Fortlage L; Santella RM; Felton JS; Knize MG; Greenberg A; Watkins PB
Gastroenterology; 1999 Jul; 117(1):89-98. PubMed ID: 10381914
[TBL] [Abstract][Full Text] [Related]
27. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
[TBL] [Abstract][Full Text] [Related]
28. Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs.
Patel J; Mitra AK
Pharmacogenomics; 2001 Nov; 2(4):401-15. PubMed ID: 11722289
[TBL] [Abstract][Full Text] [Related]
29. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
[TBL] [Abstract][Full Text] [Related]
30. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
[TBL] [Abstract][Full Text] [Related]
31. Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans.
Hajda J; Rentsch KM; Gubler C; Steinert H; Stieger B; Fattinger K
Eur J Pharm Sci; 2010 Dec; 41(5):729-35. PubMed ID: 20933082
[TBL] [Abstract][Full Text] [Related]
32. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
Patel J; Buddha B; Dey S; Pal D; Mitra AK
Am J Ther; 2004; 11(4):262-77. PubMed ID: 15266218
[TBL] [Abstract][Full Text] [Related]
33. Influence of CYP3A4, CYP3A5, and ABCB1 genotype and expression on budesonide pharmacokinetics: a possible role of intestinal CYP3A4 expression.
Ufer M; Dilger K; Leschhorn L; Daufresne L; Mosyagin I; Rosenstiel P; Haesler R; Kuehbacher T; Nikolaus S; Schreiber S; Cascorbi I
Clin Pharmacol Ther; 2008 Jul; 84(1):43-6. PubMed ID: 18322448
[TBL] [Abstract][Full Text] [Related]
34. Metabolic characterization of the major human small intestinal cytochrome p450s.
Obach RS; Zhang QY; Dunbar D; Kaminsky LS
Drug Metab Dispos; 2001 Mar; 29(3):347-52. PubMed ID: 11181505
[TBL] [Abstract][Full Text] [Related]
35. CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.
Kuypers DR; de Jonge H; Naesens M; Lerut E; Verbeke K; Vanrenterghem Y
Clin Pharmacol Ther; 2007 Dec; 82(6):711-25. PubMed ID: 17495880
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the coordinated functional activities of cytochrome P450 3A4 and P-glycoprotein in limiting the absorption of xenobiotics in Caco-2 cells.
Tran CD; Timmins P; Conway BR; Irwin WJ
J Pharm Sci; 2002 Jan; 91(1):117-28. PubMed ID: 11782903
[TBL] [Abstract][Full Text] [Related]
37. Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein.
Brimer C; Dalton JT; Zhu Z; Schuetz J; Yasuda K; Vanin E; Relling MV; Lu Y; Schuetz EG
Pharm Res; 2000 Jul; 17(7):803-10. PubMed ID: 10990198
[TBL] [Abstract][Full Text] [Related]
38. Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine.
Berggren S; Gall C; Wollnitz N; Ekelund M; Karlbom U; Hoogstraate J; Schrenk D; Lennernäs H
Mol Pharm; 2007; 4(2):252-7. PubMed ID: 17263554
[TBL] [Abstract][Full Text] [Related]
39. The impact of P-glycoprotein efflux on enterocyte residence time and enterocyte-based metabolism of verapamil.
Johnson BM; Charman WN; Porter CJ
J Pharm Pharmacol; 2001 Dec; 53(12):1611-9. PubMed ID: 11804391
[TBL] [Abstract][Full Text] [Related]
40. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients.
Shi Y; Li Y; Tang J; Zhang J; Zou Y; Cai B; Wang L
Gene; 2013 Jan; 512(2):226-31. PubMed ID: 23107770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
